These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17938988)

  • 1. Oral bisphosphonates in treatment of transient osteoporosis.
    Kibbi L; Touma Z; Khoury N; Arayssi T
    Clin Rheumatol; 2008 Apr; 27(4):529-32. PubMed ID: 17938988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient migratory osteoporosis: rapid response to pamidronate treatment.
    Carty S; Herdman G; Williams F; Srinivasan U
    J Clin Rheumatol; 2007 Jun; 13(3):138-9. PubMed ID: 17551379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncommon transient osteoporosis of pregnancy at multiple sites associated with cytomegalovirus infection: is there a link?
    Rozenbaum M; Boulman N; Rimar D; Kaly L; Rosner I; Slobodin G
    Isr Med Assoc J; 2011 Nov; 13(11):709-11. PubMed ID: 22279710
    [No Abstract]   [Full Text] [Related]  

  • 4. [Transient osteoporosis of the hip in pregnancy. Successful treatment with calcitonin: a case report].
    Laktasic-Zerjavic N; Curkovic B; Babic-Naglic D; Potocki K; Prutki M; Soldo-Juresa D
    Z Rheumatol; 2007 Oct; 66(6):510-3. PubMed ID: 17849129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of regional migratory osteoporosis.
    Spierings J; Bours S; Peeters HRM
    Osteoporos Int; 2018 Feb; 29(2):507-510. PubMed ID: 29064043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of transient osteoporosis with intravenous zoledronate: a case report.
    Maslin D; Karanth M; Bhagat S; Guirguis R
    Int J Rheum Dis; 2014 Sep; 17(7):816-7. PubMed ID: 24673857
    [No Abstract]   [Full Text] [Related]  

  • 7. [The successful development of bisphosphonates in the therapy of osteoporosis].
    Fassbender WJ; Stumpf UC; Kurth A
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of anti-resorptive therapy for osteoporosis.
    Adler RA
    Endocrine; 2016 Feb; 51(2):222-4. PubMed ID: 26433739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bisphosphonate].
    Hagino H
    Nihon Rinsho; 2011 Jul; 69(7):1253-7. PubMed ID: 21774367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates for osteoporosis in people with cystic fibrosis.
    Conwell LS; Chang AB
    Cochrane Database Syst Rev; 2012 Apr; (4):CD002010. PubMed ID: 22513903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates may help men with osteoporosis.
    Harv Health Lett; 2013 Jan; 38(3):8. PubMed ID: 23556169
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful neridronate therapy in transient osteoporosis of the hip.
    La Montagna G; Malesci D; Tirri R; Valentini G
    Clin Rheumatol; 2005 Feb; 24(1):67-9. PubMed ID: 15322945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Image assessment of the treatment effect on osteoporosis: bisphosphonates].
    Sone T
    Clin Calcium; 2011 Jul; 21(7):1041-6. PubMed ID: 21719985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How soon after hip fracture surgery should a patient start bisphosphonates?
    Seton M
    Cleve Clin J Med; 2010 Nov; 77(11):751-5. PubMed ID: 21048049
    [No Abstract]   [Full Text] [Related]  

  • 15. Transient osteoporosis of the hip: successful treatment with teriparatide.
    Fabbriciani G; Pirro M; Manfredelli MR; Bianchi M; Sivolella S; Scarponi AM; Mannarino E
    Rheumatol Int; 2012 May; 32(5):1367-70. PubMed ID: 20238219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates in the treatment of HIV-related osteoporosis.
    Vescini F; Grimaldi F
    Endocrine; 2015 Mar; 48(2):358-9. PubMed ID: 25424437
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiographic evidence of treatment with bisphosphonates.
    Thayer ML
    Br Dent J; 2017 Apr; 222(7):507-510. PubMed ID: 28387280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates for osteoporosis: benefits and risks.
    Bollerslev J; Harris ST; Leder BZ
    J Clin Endocrinol Metab; 2011 Sep; 96(9):27A, 28A. PubMed ID: 21896893
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ibandronate].
    Babić-Naglic D; Grazio S
    Reumatizam; 2006; 53(2):72-6. PubMed ID: 17580559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates for osteoporosis--where do we go from here?
    Whitaker M; Guo J; Kehoe T; Benson G
    N Engl J Med; 2012 May; 366(22):2048-51. PubMed ID: 22571168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.